Usman Nassim's Form 4 filing
Gyre Therapeutics, Inc. (GYRE) · filed May 2, 2024
- Accession no.
- 0001140361-24-024125
- Filed
- May 2, 2024
- Trade date
- May 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $282.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Usman NassimCIK 0001206872 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Common Stock | MOption exerciseAcquired | +20,000 | $6.93 | +$138,600 | 21,636 | Direct | |
| May 1, 2024 | Common Stock | SSaleDisposed | −14,900 | $13.86 | −$206,514 | 6,736 | Direct | |
| May 1, 2024 | Common Stock | SSaleDisposed | −5,000 | $14.90 | −$74,500 | 1,736 | Direct | |
| May 1, 2024 | Common Stock | SSaleDisposed | −100 | $15.63 | −$1,563 | 1,636 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 281,652 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.